Age: 9.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Inflammation, Joint swelling, Lip swelling, Peripheral swelling, Rash
Clinical narrative: swelling and rash around his eyes; swelling and rash around his eyes; swelling and inflammation on both of his hands; swelling and inflammation on both of his hands; swollen bottom lip / swollen upper lip; inflammation and swelling in his right knee / inflammation and swelling in his left knee/swelling and inflammation on both of his hands; inflammation and swelling in his right knee / inflammation and swelling in his left knee; swelling was debilitating; swollen kness prevented him from walking; swollen hand prevented him from gripping; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the parent.  A 9 year-old male patient received bnt162b2 (BNT162B2), administered in arm right, administration date 27Nov2021 14:30 (Lot number: FK5127) at the age of 9 years as dose 1, single for covid-19 immunisation. The patient had no relevant medical history. Concomitant medication taken within 2 weeks of vaccination included an unspecified daily multivitamin. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. The following information was reported: ARTHRITIS (medically significant) with onset 02Dec2021 14:30, outcome "recovered" (Dec2021), described as "inflammation and swelling in his right knee / inflammation and swelling in his left knee/swelling and inflammation on both of his hands"; JOINT SWELLING (medically significant) with onset 02Dec2021 14:30, outcome "recovered" (Dec2021), described as "inflammation and swelling in his right knee / inflammation and swelling in his left knee"; LIP SWELLING (medically significant) with onset 03Dec2021, outcome "recovered" (Dec2021), described as "swollen bottom lip / swollen upper lip"; PERIPHERAL SWELLING (medically significant), INFLAMMATION (medically significant) all with onset 04Dec2021, outcome "recovered" (Dec2021) and all described as "swelling and inflammation on both of his hands"; EYE SWELLING (medically significant), RASH (medically significant) all with onset 05Dec2021, outcome "recovered" (Dec2021) and all described as "swelling and rash around his eyes"; ASTHENIA (non-serious) with onset Dec2021, outcome "recovered" (Dec2021), described as "swelling was debilitating"; GAIT DISTURBANCE (non-serious) with onset Dec2021, outcome "recovered" (Dec2021), described as "swollen kness prevented him from walking"; GRIP STRENGTH DECREASED (non-serious) with onset Dec2021, outcome "recovered" (Dec2021), described as "swollen hand prevented him from gripping". The patient seemed to be better (recovered in Dec2021). The events "inflammation and swelling in his right knee / inflammation and swelling in his left knee/swelling and inflammation on both of his hands", "inflammation and swelling in his right knee / inflammation and swelling in his left knee", "swollen bottom lip / swollen upper lip", "swelling and inflammation on both of his hands", "swelling and rash around his eyes", "swelling and rash around his eyes", "swelling was debilitating", "swollen kness prevented him from walking" and "swollen hand prevented him from gripping" were evaluated at the physician office visit and emergency room visit. The patient underwent the following laboratory tests and procedures: sars-cov-2 test: (03Dec2021) negative. Therapeutic measures including Ibuprofen and Benadryl regimen were taken as a result of inflammation, joint swelling, lip swelling, peripheral swelling, eye swelling, rash, asthenia, gait disturbance, grip strength decreased.